Drug class
Antipsoriatics, Topical
Topical antipsoriatics are a broad class of dermatologic medications applied directly to the skin to manage localized manifestations of psoriasis, most notably mild-to-moderate plaque psoriasis. Read more about Antipsoriatics, Topical
59 drugs in this class 27 manufacturers
Drugs in Antipsoriatics, Topical
CIPOTREX (calcipotriene/transparent dressing)
ATTERO (calcipotriene/betamethasone dipropionate)
PELLIX (calcipotriene)
TRILITAS (tazarotene)
Topical antipsoriatics are a broad class of dermatologic medications applied directly to the skin to manage localized manifestations of psoriasis, most notably mild-to-moderate plaque psoriasis.
This class encompasses diverse pharmacological agents—including vitamin D analogs, retinoids, topical corticosteroids, keratolytics, anthralin, coal tar, and newer nonsteroidal immunomodulators—which act locally to suppress cutaneous inflammation, inhibit epidermal hyperproliferation, and promote normal keratinocyte differentiation.
By reducing hyperkeratosis, plaque thickness, erythema, and pruritus, these agents serve as first-line therapy for cutaneous psoriasis and can function as adjunctive treatments in more extensive disease.
-
fda.gov
Topical antipsoriatics are a broad class of dermatologic medications applied directly to the skin to manage localized manifestations of psoriasis, most notably mild-to-moderate plaque psoriasis This class encompasses diverse pharmacological agents—including vitamin D analogs, retinoids, topical corticosteroids, keratolytics, anthralin, coal tar, and newer nonsteroidal immunomodulators—which act locally to suppress cutaneous inflammation, inhibit epidermal hyperproliferation, and promote normal k...
-
fda.gov
Topical antipsoriatics are a broad class of dermatologic medications applied directly to the skin to manage localized manifestations of psoriasis, most notably mild-to-moderate plaque psoriasis
-
nih.gov
Topical antipsoriatics are a broad class of dermatologic medications applied directly to the skin to manage localized manifestations of psoriasis, most notably mild-to-moderate plaque psoriasis By reducing hyperkeratosis, plaque thickness, erythema, and pruritus, these agents serve as first-line therapy for cutaneous psoriasis and can function as adjunctive treatments in more extensive disease
-
fda.gov
This class encompasses diverse pharmacological agents—including vitamin D analogs, retinoids, topical corticosteroids, keratolytics, anthralin, coal tar, and newer nonsteroidal immunomodulators—which act locally to suppress cutaneous inflammation, inhibit epidermal hyperproliferation, and promote normal keratinocyte differentiation
-
nih.gov
This class encompasses diverse pharmacological agents—including vitamin D analogs, retinoids, topical corticosteroids, keratolytics, anthralin, coal tar, and newer nonsteroidal immunomodulators—which act locally to suppress cutaneous inflammation, inhibit epidermal hyperproliferation, and promote normal keratinocyte differentiation
-
rxlist.com
By reducing hyperkeratosis, plaque thickness, erythema, and pruritus, these agents serve as first-line therapy for cutaneous psoriasis and can function as adjunctive treatments in more extensive disease
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.